1. K. Strauss. Endocrine complications of the Acquired Immunodeficiency Syndrome. Archives of Internal Medicine, 1991; 151:1441-1444.2. A Levin, G. Brubaker, J. Shao, D. Kumby, T. O’Brien, J. Goedert, K. Strauss, W. Blattner, I. Hannet. Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. International Journal of STD & AIDS, 1996:288-291.3. F. Bouscarat, M. Levacher, M Dazza, K. Strauss, P. Girard, C. Ruggeri, M. Sinet. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Research and Human Retroviruses, 1996; 12:17-24.4. F. Hulstaert, K. Strauss, M. Levacher, G. Vanham, L. Kestens, B. Bach. The staging and prognostic value of subset markers on CD8 cells in HIV disease. In Janossy G, Autran B. Miedema F (eds): Immunodefiency in HIV Infection and AIDS, Karger Publishers, Basel, 1992:185-194.5. D. Bainbridge, M. Lowdell, I. Hannet, K. Strauss, A. Karpas. Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS? Phil. Trans. R. Soc. London. B, 1997; 352:763-770.6. A Lopez, I. Caragol, J. Candeias, N. Villamor, P. Echaniz, F. Ortuno, A. Sempere, K. Strauss, A. Orfao. Enumeration of CD4+ T-cells in the peripheral blood of HIV-infected patients: interlaboratory study of the FACSCount system. Cytometry. 1999 Oct 15;38(5):231-7.7. V. Chernyshov, E. Vykhovanets, I. Slukvin, Y. Antipkin, A. Vasyuk, K. Strauss, Analysis of blood lymphocyte subsets in children living on territory that received high amounts of fallout from Chernobyl accident. Clinical Immunology and Immunopathology, 1997:122-128.8. F. Hulstaert, I. Hannet, V. Deneys, V. Munhyeshuli, T. Reichert, M. DeBruyer, K. Strauss. Age-related changes in Human blood lymphocyte subpopulations. Clinical Immunology and Immunopathology, 1994; 70:152-158.9. K. Strauss, I. Hannet, S. Engels, A. Shiba, D. Ward, S. Ullery, M. Jinguji, J. Valinsky, D. Barnett, A. Orfao, L. Kestens. Performance Evaluation of the FACSCount system: a dedicated system for clinical cellular analysis. Cytometry, 1996; 26:52-59.10. B. Bertino, W. Knape, M. Pytlinska, K. Strauss, J-C. Hammou. A comparative study of DNA content as measured by flow cytometry and image analysis in 1864 specimens. Analytical Cellular Pathology, 1994; 6:377-394.11. K.Strauss, F. Hulstaert, V. Deneys, A. Mazzon, I. Hannet, M. DeBruyere, T. Reichert, C. Sindic. The immune profile of multiple sclerosis: T-lymphocyte effects predominate over all other factors in cyclophosphamide-treated patients. Journal of Neuroimmunology 1995; 63:133-142.12. R. Vesely, J. Barths, F. Vanlangendonck, I. Hannet, K. Strauss. Initial results of Central European Immunophenogyping Quality Control Program (CEQUAL). Cytometry 26:108-112.13. F. Hulstaert, J. Albrecht, I. Hannet, P. Lancaster, L. Buchner, J. Kunz, A. Falkenrodt, M. Tongio, F. DeKeyser, E. Veys, L. Noens, N. Mir, C. Costello, R. Becker, K. Strauss. An optimized method for routine HLA-B27 screening using flow cytometry. Cytometry, 1994; 18:21-29.14. K. Strauss, Insulin injection techniques: Report from the 1st International Insulin Injection Technique Workshop, Strasbourg, France...June 1997, Practical Diabetes International, September 1998:15; 16-20.15. K. Strauss, I. Hannet, J. McGonigle, JL. Parkes, B. Ginsberg, R. Jamal, A. Frid, Ultra-short (5mm) insulin needles: trial results and clinical recommendations. Practical Diabetes International, October 1999: 16; 22-25.16. J. Wilczynski, K. Cypryk, K. Strauss, R. Mazze. The role of Staged Diabetes Management in improving diabetes care in Poland. Practical Diabetes Management, August 1999; 16:137-141.17. K. Strauss. Ultra short (5mm) insulin needles: how do they affect injection technique? ISPAD, April 1999, 127-132.18. Look D, Strauss K. Nadeln mehrfach verwenden? Diabetes Journal 1998, 10: S. 31-34.19. K. Strauss, Pautas de insulinoterapia y técnicas de inyección, Anales de Medicina Interna, May 1998:292-293.20. K. Strauss, Strumenti per la somministrazione dell-insulina e tecniche corrette per la sua iniezione. Il Diabete, Sept. 1997; 9:157-167.21. K. Strauss. Bezpieczenstwo I wygoda wstrzykiwania insuliny. Diabetologia Polska, 1995; 2:305-308.22. K. Strauss, B. Ginsberg. Managing type II diabetes. European Union of General Practitioners Reference Book 1996/97.23. K. Strauss, H. De Gols, I. Hannet, TM Partanen, A Frid. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int; April 2002, Vol 19:71-76.24. K Strauss, R Onia, A van Zundert. Peripheral Intravenous Catheter Use in Europe: Towards the use of safety devices. Acta Anaesthesiol Scand 2008; In press.25. AM Rivera, K Strauss, A Van Zundert, E Mortier. The history of peripheral intravenous catheters: How plastic tubes revolutionized medicine. Acta Anaesthesiol Belg 2005; 56:271-282.26. AM Rivera, K Strauss, A Van Zundert, E Mortier. Matching the peripheral intravenous catheter to the individual patient. Acta Anaesthesiol Belg 2006; 58:19-25.27. K Strauss, A van Zundert, A Frid, V Costigliola. Pandemic influenza preparedness : the critical role of the syringe.. Vaccine. 2006 May 29;24(22):4874-82. Epub 2006 Mar 20.28. K Strauss. ‘Safety in Family Medicine’, The European Textbook of Family Medicine, eds. M Bisconcin, G. Maso, N. Mathers. 2006: Passoni Editore, pp. 687-696.